3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
5
Lung Neoplasms
5
Mouth Neoplasms
4
Mesothelioma, Malignant
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma
4
Urinary Bladder Neoplasms
3
Nasopharyngeal Carcinoma
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Interventions
Bevacizumab
25
Fluorouracil
23
Leucovorin
22
Cetuximab
22
Oxaliplatin
19
pembrolizumab
14
Specimen Handling
11
Irinotecan
10
Nivolumab
8
Magnetic Resonance Spectroscopy
8
Biopsy
7
atezolizumab
6
fludarabine
5
encorafenib
5
Pemetrexed
5
Panitumumab
5
HMPL-013
5
Gemcitabine
5
Folfox protocol
5
Cisplatin
5
Carboplatin
5
trifluridine tipiracil drug combination
4
balstilimab
4
Standard of Care
4
Immunoglobulin G
4
Disulfides
4
Cyclophosphamide
4
regorafenib
3
fludarabine phosphate
3
dehydroftorafur
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Platinum
×
30 days
×
Clear all
No trials found.